These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
532 related items for PubMed ID: 19332190
21. Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes. Krimly A, Yan RT, Yan AT, DeYoung JP, Gallo R, Steg G, Eikelboom J, Gore JM, Fox KA, Fitchett D, Quantz MA, Goodman SG. Can J Cardiol; 2011; 27(6):711-5. PubMed ID: 21875778 [Abstract] [Full Text] [Related]
22. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, Peters G, Wickens M, Emanuelsson H, Gurbel P, Grande P, Cannon CP. J Am Coll Cardiol; 2007 Nov 06; 50(19):1852-6. PubMed ID: 17980251 [Abstract] [Full Text] [Related]
27. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. Weintraub WS, Mahoney EM, Lamy A, Culler S, Yuan Y, Caro J, Gabriel S, Yusuf S, CURE Study Investigators. J Am Coll Cardiol; 2005 Mar 15; 45(6):838-45. PubMed ID: 15766816 [Abstract] [Full Text] [Related]
29. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial. Zeymer U, Gitt A, Jünger C, Bauer T, Heer T, Koeth O, Mark B, Zahn R, Senges J, Gottwik M. Thromb Haemost; 2008 Jan 15; 99(1):155-60. PubMed ID: 18217148 [Abstract] [Full Text] [Related]
30. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. Elbarouni B, Ismaeil N, Yan RT, Fox KA, Connelly KA, Baer C, DeYoung JP, Gallo R, Ramanathan K, Pesant Y, Leiter LA, Goodman SG, Yan AT. Am Heart J; 2011 Aug 15; 162(2):347-355.e1. PubMed ID: 21835297 [Abstract] [Full Text] [Related]
34. [Treatment of the acute coronary syndrome in Germany: experiences in a German cluster of the GRACE registry]. Tebbe U, Bramlage P, von Löwis of Menar P, Lawall H, Gaudron P, Lüders S, Klaus A, Lengfelder W, Scholz KH, Maziejewski S, Cuneo A, Hohmann V, Gulba D. Dtsch Med Wochenschr; 2007 Sep 15; 132(39):2000-5. PubMed ID: 17882737 [Abstract] [Full Text] [Related]
36. Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complications. Motivala AA, Tamhane U, Saab F, Li J, Rogers EK, Froehlich J, Moscucci M, Eagle KA, Gurm HS. Am J Cardiol; 2007 Nov 01; 100(9):1359-63. PubMed ID: 17950790 [Abstract] [Full Text] [Related]
39. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada. Elbarouni B, Goodman SG, Yan RT, Welsh RC, Kornder JM, Deyoung JP, Wong GC, Rose B, Grondin FR, Gallo R, Tan M, Casanova A, Eagle KA, Yan AT, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE(2)) Investigators. Am Heart J; 2009 Sep 01; 158(3):392-9. PubMed ID: 19699862 [Abstract] [Full Text] [Related]
40. Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes. Moriel M, Tzivoni D, Behar S, Zahger D, Hod H, Hasdai D, Sandach A, Gottlieb S. Int J Cardiol; 2008 Dec 17; 131(1):97-104. PubMed ID: 18222551 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]